Form 4 for BIIB Biogen
Accepted 2023-12-12 00:00:00 ET · period of report 2023-12-08 · accession 0001127602-23-029445 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-12 | 2023-12-08 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +426 | 3,780 | +13% | $0 |
| D | 2023-12-12 | 2023-12-08 | BIIB | Singhal Priya | Head of Development | F - Tax | $239.29 | -206 | 3,574 | -5% | -$49.3K |
| D | 2023-12-12 | 2023-12-11 | BIIB | Singhal Priya | Head of Development | S - Sale+OE | $248.00 | -110 | 3,464 | -3% | -$27.3K |
| D | 2023-12-12 | 2023-12-08 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | -426 | 426 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-08 | M | A | 426 | $0.00 | 3,780.09 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-08 | F | D | 206 | $239.29 | 3,574.09 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-11 | S | D | 110 | $248.00 | 3,464.09 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2023-12-08 | M | D | 426 | $0.00 | 426 | D | $0.00 · — to 2024-12-08 | 426 Common Stock | (F1) This award was granted to the reporting person on December 8, 2021 and will vest in three equal installments on each anniversary of the grant date. |